Skip to main content

1 Result(s)

within Mengqiu Xu Remove this filter Medicine & Public Health Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies

    High rates of relapse and poor prognosis confer an urgent need for novel therapeutic agents for B cell non-Hodgkin lymphomas (B-NHLs). Herein, we describe a human IgG-like anti-CD79b/CD3 bispecific antibody (I...

    Jie Wang, Chen Li, Kaijie He, Zhihui Kuang, Jia Lu… in Cancer Immunology, Immunotherapy (2023)